Wells Fargo & Company »

Janux Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $230k 6.1k 37.65
2023-12-31 $57k 5.3k 10.73
2023-09-30 $43k 4.3k 10.08
2023-06-30 $79k 6.6k 11.87
2022-09-30 $999 45 22.22
2022-06-30 $322k 30k 10.87
2022-03-31 $68k 4.7k 14.34
2021-12-31 $163k 8.2k 19.78
2021-09-30 $2.0k 74 27.03